- Approval Id
- d43d98944cc64fee
- Drug Name
- HYALGAN INJECTION 20 mg/2 ml
- Product Name
- HYALGAN INJECTION 20 mg/2 ml
- Approval Number
- SIN06242P
- Approval Date
- 1991-06-22
- Registrant
- PHARMAFORTE SINGAPORE PTE LTD
- Licence Holder
- PHARMAFORTE SINGAPORE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION
- Dosage
- **Posology and Method of Administration –**
**Adults (including the elderly)** The contents of one vial (20mg/2ml) or prefilled syringe (20mg/2ml) to be injected into the affected joint once a week for a total of five injections, using a standard technique. No adjustment of dose is required in elderly patients. This can be repeated at not less than 6 monthly intervals.
**Children –** At present there is not enough evidence to recommend a dosage regimen for use in children.
- Route Of Administration
- INTRA-ARTICULAR
- Indication Info
- **Therapeutic Indications –** Treatment / sustained relief of pain in osteoarthritis of the knee.
- Contraindications
- **Contra-indications –** Hyalectin®, the active principle in Hyalgan®, is of avian origin. Do not administer to patients with known hypersensitivity to any ingredient of the product or to avian proteins.
Intra-articular injections are contra-indicated in cases of infections or skin diseases in the area of the injection site.
- Atc Code
- S01KA01
- Atc Item Name
- hyaluronic acid
- Pharma Manufacturer Name
- PHARMAFORTE SINGAPORE PTE LTD
- Company Detail Path
- /organization/pharmaforte-singapore-pte-ltd
